期刊文献+

生物瓣的使用存在年龄限制吗? 被引量:3

Is there an age limit for the use of biologic valve?
原文传递
导出
摘要 近年来,生物瓣在国外的使用量持续增长而机械瓣的使用量则有所下降,在国内亦有相同的变化趋势。不少学者提出患者年龄不再是瓣膜选择的关键因素,并建议将生物瓣的推荐使用年龄由65岁降至60岁,甚至60岁以下,引起了较大的争议,现综述如下。 Summary In recent years, application of biologic valve has increased steadily abroad whereas mechanical valve usage has decreased. It is a similar trend in China. Quite a few scholars advocate that patient age is no longer the critical factor for selection of valve prostheses, and recommend application of biologic valves in patients aged 60 years, even in patients younger than 60 years. Age limit for the use of biologic valve is intensely debated. Here, we will discuss it in detail.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2014年第9期745-748,共4页 Journal of Clinical Cardiology
关键词 心脏瓣膜置换术 生物瓣 机械瓣 瓣膜的选择 heart valve replacement biologic valve mechanical valve selection of valve prostheses
  • 相关文献

参考文献28

  • 1BROWN J M, CrBRIEN S M, WU C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Sur- geons National Database[J]. J Thoracic Cardiovasc Surg, 2009, 137: 82-90.
  • 2STASSANO P, DI TOMMASO L, MONACO M, et al. Aortic Valve ReplacementA Prospective Random- ized Evaluation of Mechanical Versus Biological Valves in Patients Ages 55 to 70 Years[J]. J Am Coll Cardiol, 2009, 54: 1862-1868.
  • 3VAN GELDORP M W A, ERIC JAMIESON W R, KAPPETEIN A P, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related e- vent risk against reoperation risk[J]. J Thoracic Card- iovasc Surg, 2009, 137: 881-886.
  • 4CHAN V, JAMIESON W R E, GERMANN E, et al. Performance of bioprostheses and mechanical pros- theses assessed by composites of valve-related compli- cations to 15 years after aortic valve replacement[J]. J Thoracic Cardiovasc Surg, 2006, 131: 1267-1273.
  • 5PRASONGSUKARN K, JAMIESON W R, LICHT- ENSTEIN S V. Performance of bioprostheses and mechanical prostheses in age group 61-70 yearsI-J. J Heart Valve Dis, 2005, 14: 501-505.
  • 6LUND O, BLAND M. Risk-corrected impact of me- chanical versus bioprosthetic valves on long-term mor- tality after aortic valve replacement [J]. J Thoracic Cardiovasc Surg, 2006, 132: 20-26.
  • 7RUEL M, CHAN V, BEDARD P, et al. Very long- term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults 60 years of age[J]. Circulation, 2007, 116(11 sup-pl) : 1294-1300.
  • 8HAMMERMEISTER K, SETHI G K, HENDER- SON W G, et al. Outcomes 15 years after valve re- placement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial[J]. J Am Coll Cardiol, 2000, 36: 1152-1158.
  • 9BLOOMFIELD P, WHEATLEY D J, PRESCOTT R J, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses[J]. N EnglJ Med, 1991, 324 573-579.
  • 10HYLEK E M, EVANS-MOLINA C, SHEA C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation[J]. Circulation, 2007, 115: 2689- 2696.

同被引文献10

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部